Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Thescientificworldjournal|March 9, 2010
Cucurbitacin: ancient compound shedding new light on cancer treatmentDhong Hyun Lee, Gabriela B Iwanski, Nils H Thoennissen
Neurological Research|October 4, 2005
Can Doppler time domain analysis of microembolic signals discriminate between gaseous and solid microemboli in patients with left ventricular assist device?Nils H Thoennissen, Achim Allroggen, Ralf Dittrich, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 9, 2006
Influence of inflammation and pump dynamic on cerebral microembolization in patients with Continuous-Flow DeBakey LVADNils H Thoennissen, Achim Allroggen, Martin Ritter, et al.
Digestive Diseases and Sciences|October 5, 2014
The risk of colorectal cancer in patients with ulcerative colitisTobias M Nowacki, Markus Brückner, Maria Eveslage, et al.
Plos One|November 13, 2010
In vivo deficiency of both C/EBPβ and C/EBPε results in highly defective myeloid differentiation and lack of cytokine responseTadayuki Akagi, Nils H Thoennissen, Ann George, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 11, 2005
High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist deviceNils H Thoennissen, Michael Schneider, Achim Allroggen, et al.
Clinical Sarcoma Research|November 21, 2015
Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CTPanagiotis Karagiannis, Nina Guth, Gabriela B Thoennissen, et al.
Cancer Letters|March 29, 2011
Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcomaDhong Hyun Lee, Nils H Thoennissen, Catherine Goff, et al.
Leukemia & Lymphoma|January 21, 2012
Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphomaNils H Thoennissen, Gabriela B Thoennissen, Sam Abbassi, et al.
Annals of Hematology|May 1, 2012
POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experienceGabriela B Thoennissen, Nils H Thoennissen, Fleur Fritz, et al.
Pageof 3